中國銀行(03988.HK):第三期境內優先股股息將於6月27日派付
格隆匯6月16日丨中國銀行(03988.HK)公佈,該行2019年第一次臨時股東大會審議通過了《中國銀行股份有限公司境內非公開發行優先股方案》,授權董事會依照發行合同的約定,宣派和支付全部本次境內優先股股息。此次第三期境內優先股(上海證券交易所優先股代碼:360033;優先股簡稱:中行優3)股息派發方案已經該行2022年4月29日召開的2022年第三次董事會會議審議通過。
股權登記日為2022年6月24日,股息發放日為2022年6月27日,按照第三期境內優先股票面股息率4.50%計算,每股優先股派發現金股息人民幣4.50元(税前)。以第三期境內優先股發行量7.3億股為基數,該行此次派發現金股息共計人民幣32.85億元(税前)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.